EUVIMEDEUVIMED entdecken
Crossref

In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway

Huixian Zhou, Zhiwen Wu, Yannan Zhang, Zikai Yu, Zhengyang Nie, Jinbiao Fan, Zuchang Zhu, Fenglian Chen, Tao Wang

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-10833-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Huixian Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China. Hauptthemen laut MEDLINE: Curcumin, Proto-Oncogene Proteins c-akt, Tumor Suppressor Protein p53, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Guangzhou University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminProto-Oncogene Proteins c-aktTumor Suppressor Protein p53Antineoplastic AgentsPhosphatidylinositol 3-KinasesSignal TransductionHumansApoptosisMolecular Docking SimulationCell ProliferationCell Line, TumorMCF-7 Cells

Stichwörter der Autor:innen

AntitumorCurcumin derivativesKnoevenagel condensationPI3K/Akt/p53 pathway

Substanzen

CurcuminProto-Oncogene Proteins c-aktTumor Suppressor Protein p53Antineoplastic AgentsPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China.
  • Technological R&D department, Lizhu Pharmaceutical Co., Ltd, Zhuhai, Guangdong, 519000, People's Republic of China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China. fenglian@gzucm.edu.cn.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, People's Republic of China. wangtao@gzucm.edu.cn.

Förderung

  • Guangzhou University of Chinese Medicine

Zitieren

APA

Zhou, H., Wu, Z., Zhang, Y., Yu, Z., Nie, Z., Fan, J., Zhu, Z., Chen, F., & Wang, T. (2025). In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway. Molecular Diversity. https://doi.org/10.1007/s11030-024-10833-9

Vancouver

Zhou H, Wu Z, Zhang Y, Yu Z, Nie Z, Fan J, et al. In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway. Molecular Diversity. 2025. doi:10.1007/s11030-024-10833-9

BibTeX
@article{Zhou2025,
  author = {Zhou, Huixian and Wu, Zhiwen and Zhang, Yannan and Yu, Zikai and Nie, Zhengyang and Fan, Jinbiao and Zhu, Zuchang and Chen, Fenglian and Wang, Tao},
  title = {In vitro anticancer study of novel curcumin derivatives via targeting PI3K/Akt/p53 signaling pathway},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-10833-9}
}
Kostenlos starten →